These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2851633)

  • 1. Intraocular pressure, ocular toxicity and neurotoxicity in response to 11-hydroxy-delta 9-tetrahydrocannabinol and 1-nantradol.
    Colasanti BK
    J Ocul Pharmacol; 1985; 1(2):123-35. PubMed ID: 2851633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraocular pressure, ocular toxicity and neurotoxicity after administration of delta 9-tetrahydrocannabinol or cannabichromene.
    Colasanti BK; Powell SR; Craig CR
    Exp Eye Res; 1984 Jan; 38(1):63-71. PubMed ID: 6323206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the ocular and central effects of delta 9-tetrahydrocannabinol and cannabigerol.
    Colasanti BK
    J Ocul Pharmacol; 1990; 6(4):259-69. PubMed ID: 1965836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ocular hypotension, ocular toxicity, and neurotoxicity in response to marihuana extract and cannabidiol.
    Colasanti BK; Brown RE; Craig CR
    Gen Pharmacol; 1984; 15(6):479-84. PubMed ID: 6098513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraocular pressure following systemic administration of cannabinoids.
    Green K; Symonds CM; Oliver NW; Elijah RD
    Curr Eye Res; 1982-1983; 2(4):247-53. PubMed ID: 6295702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of delta 9-tetrahydrocannabinol on intraocular pressure after removal of autonomic input.
    Colasanti BK; Powell SR
    J Ocul Pharmacol; 1985; 1(1):47-57. PubMed ID: 2851632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of THC, nantradol, nabilone, and morphine in the chronic spinal dog.
    Gilbert PE
    J Clin Pharmacol; 1981; 21(S1):311S-319S. PubMed ID: 6271835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological potency of R- and S-3'-hydroxy-delta 9-tetrahydrocannabinol: additional structural requirement for cannabinoid activity.
    Martin BR; Kallman MJ; Kaempf GF; Harris LS; Dewey WL; Razdan RK
    Pharmacol Biochem Behav; 1984 Jul; 21(1):61-5. PubMed ID: 6087379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraocular pressure, ocular toxicity and neurotoxicity after administration of cannabinol or cannabigerol.
    Colasanti BK; Craig CR; Allara RD
    Exp Eye Res; 1984 Sep; 39(3):251-9. PubMed ID: 6499952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discriminative stimulus- and open-field effects of the enantiomers of 11-hydroxy-delta-8-tetrahydrocannabinol in pigeons and gerbils.
    Järbe TU; Mechoulam R; Zahalka J
    Pharmacol Biochem Behav; 1994 Jan; 47(1):113-9. PubMed ID: 8115412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delta(9)-tetrahydrocannabinol, 11-hydroxy-delta(9)-tetrahydrocannabinol and 11-nor-9-carboxy-delta(9)-tetrahydrocannabinol in human plasma after controlled oral administration of cannabinoids.
    Goodwin RS; Gustafson RA; Barnes A; Nebro W; Moolchan ET; Huestis MA
    Ther Drug Monit; 2006 Aug; 28(4):545-51. PubMed ID: 16885723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-tolerance to the hypothermic effect of delta 8-tetrahydrocannabinol 11-hydroxy-delta 8-tetrahydrocannabinol and chlorpromazine in the mouse.
    Yamamoto I; Watanabe K; Narimatsu S; Hamajima K; Yoshimura H
    Eur J Pharmacol; 1985 May; 111(2):159-66. PubMed ID: 2990949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A submicron emulsion as ocular vehicle for delta-8-tetrahydrocannabinol: effect on intraocular pressure in rabbits.
    Muchtar S; Almog S; Torracca MT; Saettone MF; Benita S
    Ophthalmic Res; 1992; 24(3):142-9. PubMed ID: 1328979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic exposure to delta 9-tetrahydrocannabinol fails to irreversibly alter brain cannabinoid receptors.
    Westlake TM; Howlett AC; Ali SF; Paule MG; Scallet AC; Slikker W
    Brain Res; 1991 Mar; 544(1):145-9. PubMed ID: 1649662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of delta 9-tetrahydrocannabinol on intraocular pressure in the anaesthetized cat.
    Innemee HC; Hermans AJ; van Zwieten PA
    Doc Ophthalmol; 1980 Apr; 48(2):235-41. PubMed ID: 6249559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discriminative stimulus properties of delta 9-tetrahydrocannabinol: mechanistic studies.
    Browne RG; Weissman A
    J Clin Pharmacol; 1981; 21(S1):227S-234S. PubMed ID: 6271828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of repeated administration of 11-hydroxy-delta 8-tetrahydrocannabinol, an active metabolite of delta 8-tetrahydrocannabinol, on the hepatic microsomal drug-metabolizing enzyme system of mice.
    Watanabe K; Arai M; Narimatsu S; Yamamoto I; Yoshimura H
    Biochem Pharmacol; 1986 Jun; 35(11):1861-5. PubMed ID: 3013200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a Δ9-Tetrahydrocannabinol Amino Acid-Dicarboxylate Prodrug With Improved Ocular Bioavailability.
    Adelli GR; Bhagav P; Taskar P; Hingorani T; Pettaway S; Gul W; ElSohly MA; Repka MA; Majumdar S
    Invest Ophthalmol Vis Sci; 2017 Apr; 58(4):2167-2179. PubMed ID: 28399267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of agonist-antagonist properties of nitrogen mustard and cyano derivatives of delta 8-tetrahydrocannabinol.
    Wiley JL; Compton DR; Gordon PM; Siegel C; Singer M; Dutta A; Lichtman AH; Balster RL; Razdan RK; Martin BR
    Neuropharmacology; 1996; 35(12):1793-804. PubMed ID: 9076759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic cannabinoid administration alters cannabinoid receptor binding in rat brain: a quantitative autoradiographic study.
    Oviedo A; Glowa J; Herkenham M
    Brain Res; 1993 Jul; 616(1-2):293-302. PubMed ID: 8395305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.